alpha1-Antitrypsin inhibits the lethal response to TNF in mice

J Immunol. 1996 Dec 1;157(11):5126-9.

Abstract

alpha1-Antitrypsin, an acute-phase reactant in many species, protects significantly against the lethality induced by TNF or endotoxin in mice. The protection is optimal with a single dose of at least 300 microg i.p. or 100 microg i.v. given 2 h before a lethal challenge, either with a low dose of TNF in the presence of galactosamine or a higher dose of murine TNF alone. Under optimal conditions, the drop in body temperature, the release of liver transaminases, and the increase in clotting time are also inhibited. alpha1-Antitrypsin does not protect against a lethal dose of platelet-activating factor. It is suggested that the protection is due to reduced release of platelet-activating factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Blood Coagulation / drug effects
  • Body Temperature / drug effects
  • Drug Interactions
  • Female
  • Galactosamine / administration & dosage
  • Liver / drug effects
  • Liver / enzymology
  • Mice
  • Mice, Inbred C57BL
  • Platelet Activating Factor / metabolism
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / toxicity*
  • alpha 1-Antitrypsin / administration & dosage
  • alpha 1-Antitrypsin / pharmacology*
  • alpha 1-Antitrypsin / physiology

Substances

  • Platelet Activating Factor
  • Tumor Necrosis Factor-alpha
  • alpha 1-Antitrypsin
  • Galactosamine
  • Aspartate Aminotransferases
  • Alanine Transaminase